"arginine paradox" in cardiomyocytes of Sprague Dawley and spontaneously hypertensive rats: α2-adrenoreceptor-mediated regulation of L-type Ca2+ currents by L-arginine

M. N. Nenov, A. V. Berezhnov, E. I. Fedotova, K. S. Grushin, O. Yu Pimenov, A. N. Murashev, V. P. Zinchenko, Yu M. Kokoz

Research output: Contribution to journalArticle

Abstract

The "arginine paradox" in cardiomyocytes isolated from the left ventricle of Spraque Dawlay (SD) and spontaneously hypertensive rats (SHR) was studied. With 1 mM L-arginine in the bath, the addition of 5 mM L-arginine to incubation medium increased NO production and inhibited amplitude of L-type Ca2+ currents in SD cardiomyocytes. A variety of compounds, including the antagonist of α2-adrenoceptors yohimbine and inhibitors of PI3 kinase (wortmanine), NO synthase (7NI), and cGMP-dependent protein kinase (KT5823), dramatically weakened the inhibitory effects of 5 mM L-arginine on Ca2+ currents. The agonist of α2-adrenoceptors guanabenz acetate increased NO production and inhibited Ca2+ currents, while wortmanine, 7NI, and KT5823 antagonized guanabenz. In SHR cardiomyocytes, the "arginine paradox" was not observed: 5 mM L-arginine affected neither NO production nor Ca2+ currents. Consistently, guanabenz acetate did not alter NO production and inhibited Ca2+ currents to a much smaller extent in SHR cardiomyocytes as compared to SD cardiomyocytes. Taken together, the data of the inhibitory analysis suggest that millimolar L-arginine serves as an agonist of α2-adrenoceptors, which are coupled to PI3K-Akt pathway as well as downstream NO-cGMP pathway to control activity of L-type Ca2+ channels, thus providing new insights into the "arginine paradox" in cardiomyocytes.

Original languageEnglish (US)
Pages (from-to)374-382
Number of pages9
JournalBiochemistry (Moscow) Supplement Series A: Membrane and Cell Biology
Volume4
Issue number4
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Inbred SHR Rats
Cardiac Myocytes
Arginine
Rats
Guanabenz
Adrenergic Receptors
Phosphatidylinositol 3-Kinases
Cyclic GMP-Dependent Protein Kinases
Yohimbine
Baths
Nitric Oxide Synthase
Heart Ventricles

Keywords

  • α-adrenoceptors
  • arginine paradox
  • cardiomyocytes
  • L-type Ca currents
  • NO-cGMP pathway
  • PI3K-Akt pathway

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology

Cite this

"arginine paradox" in cardiomyocytes of Sprague Dawley and spontaneously hypertensive rats : α2-adrenoreceptor-mediated regulation of L-type Ca2+ currents by L-arginine. / Nenov, M. N.; Berezhnov, A. V.; Fedotova, E. I.; Grushin, K. S.; Pimenov, O. Yu; Murashev, A. N.; Zinchenko, V. P.; Kokoz, Yu M.

In: Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, Vol. 4, No. 4, 12.2010, p. 374-382.

Research output: Contribution to journalArticle

Nenov, M. N. ; Berezhnov, A. V. ; Fedotova, E. I. ; Grushin, K. S. ; Pimenov, O. Yu ; Murashev, A. N. ; Zinchenko, V. P. ; Kokoz, Yu M. / "arginine paradox" in cardiomyocytes of Sprague Dawley and spontaneously hypertensive rats : α2-adrenoreceptor-mediated regulation of L-type Ca2+ currents by L-arginine. In: Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 2010 ; Vol. 4, No. 4. pp. 374-382.
@article{f8236db49e474861b63cf92df771a5b0,
title = "{"}arginine paradox{"} in cardiomyocytes of Sprague Dawley and spontaneously hypertensive rats: α2-adrenoreceptor-mediated regulation of L-type Ca2+ currents by L-arginine",
abstract = "The {"}arginine paradox{"} in cardiomyocytes isolated from the left ventricle of Spraque Dawlay (SD) and spontaneously hypertensive rats (SHR) was studied. With 1 mM L-arginine in the bath, the addition of 5 mM L-arginine to incubation medium increased NO production and inhibited amplitude of L-type Ca2+ currents in SD cardiomyocytes. A variety of compounds, including the antagonist of α2-adrenoceptors yohimbine and inhibitors of PI3 kinase (wortmanine), NO synthase (7NI), and cGMP-dependent protein kinase (KT5823), dramatically weakened the inhibitory effects of 5 mM L-arginine on Ca2+ currents. The agonist of α2-adrenoceptors guanabenz acetate increased NO production and inhibited Ca2+ currents, while wortmanine, 7NI, and KT5823 antagonized guanabenz. In SHR cardiomyocytes, the {"}arginine paradox{"} was not observed: 5 mM L-arginine affected neither NO production nor Ca2+ currents. Consistently, guanabenz acetate did not alter NO production and inhibited Ca2+ currents to a much smaller extent in SHR cardiomyocytes as compared to SD cardiomyocytes. Taken together, the data of the inhibitory analysis suggest that millimolar L-arginine serves as an agonist of α2-adrenoceptors, which are coupled to PI3K-Akt pathway as well as downstream NO-cGMP pathway to control activity of L-type Ca2+ channels, thus providing new insights into the {"}arginine paradox{"} in cardiomyocytes.",
keywords = "α-adrenoceptors, arginine paradox, cardiomyocytes, L-type Ca currents, NO-cGMP pathway, PI3K-Akt pathway",
author = "Nenov, {M. N.} and Berezhnov, {A. V.} and Fedotova, {E. I.} and Grushin, {K. S.} and Pimenov, {O. Yu} and Murashev, {A. N.} and Zinchenko, {V. P.} and Kokoz, {Yu M.}",
year = "2010",
month = "12",
doi = "10.1134/S1990747810040070",
language = "English (US)",
volume = "4",
pages = "374--382",
journal = "Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology",
issn = "1990-7478",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "4",

}

TY - JOUR

T1 - "arginine paradox" in cardiomyocytes of Sprague Dawley and spontaneously hypertensive rats

T2 - α2-adrenoreceptor-mediated regulation of L-type Ca2+ currents by L-arginine

AU - Nenov, M. N.

AU - Berezhnov, A. V.

AU - Fedotova, E. I.

AU - Grushin, K. S.

AU - Pimenov, O. Yu

AU - Murashev, A. N.

AU - Zinchenko, V. P.

AU - Kokoz, Yu M.

PY - 2010/12

Y1 - 2010/12

N2 - The "arginine paradox" in cardiomyocytes isolated from the left ventricle of Spraque Dawlay (SD) and spontaneously hypertensive rats (SHR) was studied. With 1 mM L-arginine in the bath, the addition of 5 mM L-arginine to incubation medium increased NO production and inhibited amplitude of L-type Ca2+ currents in SD cardiomyocytes. A variety of compounds, including the antagonist of α2-adrenoceptors yohimbine and inhibitors of PI3 kinase (wortmanine), NO synthase (7NI), and cGMP-dependent protein kinase (KT5823), dramatically weakened the inhibitory effects of 5 mM L-arginine on Ca2+ currents. The agonist of α2-adrenoceptors guanabenz acetate increased NO production and inhibited Ca2+ currents, while wortmanine, 7NI, and KT5823 antagonized guanabenz. In SHR cardiomyocytes, the "arginine paradox" was not observed: 5 mM L-arginine affected neither NO production nor Ca2+ currents. Consistently, guanabenz acetate did not alter NO production and inhibited Ca2+ currents to a much smaller extent in SHR cardiomyocytes as compared to SD cardiomyocytes. Taken together, the data of the inhibitory analysis suggest that millimolar L-arginine serves as an agonist of α2-adrenoceptors, which are coupled to PI3K-Akt pathway as well as downstream NO-cGMP pathway to control activity of L-type Ca2+ channels, thus providing new insights into the "arginine paradox" in cardiomyocytes.

AB - The "arginine paradox" in cardiomyocytes isolated from the left ventricle of Spraque Dawlay (SD) and spontaneously hypertensive rats (SHR) was studied. With 1 mM L-arginine in the bath, the addition of 5 mM L-arginine to incubation medium increased NO production and inhibited amplitude of L-type Ca2+ currents in SD cardiomyocytes. A variety of compounds, including the antagonist of α2-adrenoceptors yohimbine and inhibitors of PI3 kinase (wortmanine), NO synthase (7NI), and cGMP-dependent protein kinase (KT5823), dramatically weakened the inhibitory effects of 5 mM L-arginine on Ca2+ currents. The agonist of α2-adrenoceptors guanabenz acetate increased NO production and inhibited Ca2+ currents, while wortmanine, 7NI, and KT5823 antagonized guanabenz. In SHR cardiomyocytes, the "arginine paradox" was not observed: 5 mM L-arginine affected neither NO production nor Ca2+ currents. Consistently, guanabenz acetate did not alter NO production and inhibited Ca2+ currents to a much smaller extent in SHR cardiomyocytes as compared to SD cardiomyocytes. Taken together, the data of the inhibitory analysis suggest that millimolar L-arginine serves as an agonist of α2-adrenoceptors, which are coupled to PI3K-Akt pathway as well as downstream NO-cGMP pathway to control activity of L-type Ca2+ channels, thus providing new insights into the "arginine paradox" in cardiomyocytes.

KW - α-adrenoceptors

KW - arginine paradox

KW - cardiomyocytes

KW - L-type Ca currents

KW - NO-cGMP pathway

KW - PI3K-Akt pathway

UR - http://www.scopus.com/inward/record.url?scp=78651402159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651402159&partnerID=8YFLogxK

U2 - 10.1134/S1990747810040070

DO - 10.1134/S1990747810040070

M3 - Article

AN - SCOPUS:78651402159

VL - 4

SP - 374

EP - 382

JO - Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

JF - Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

SN - 1990-7478

IS - 4

ER -